Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"novel transcript, antisense to TACR2" (ENSG00000299486) is an annotated noncoding RNA locus overlapping the TACR2 gene in an antisense orientation. Natural antisense transcripts are widespread in the human genome and often function by regulating the expression of their corresponding sense gene through diverse mechanisms, including RNA masking, modulation of alternative splicing, recruitment of chromatin-modifying complexes, and transcriptional interference[2][4][5]. While the functional significance of the specific antisense transcript at this locus remains unknown, NATs can affect the stability, splicing, or translation of the corresponding sense mRNA, or recruit epigenetic silencing marks. There is no evidence that this particular transcript is a protein, a therapeutic target, or has established clinical relevance independently from its sense gene (TACR2)[1]. This transcript is sometimes included in gene annotation databases due to widespread antisense transcription, but unless specific functional, clinical, or mechanistic data are published, it should not be regarded as a therapeutic target. The canonical protein-coding gene at this locus is Tachykinin receptor 2 (TACR2), also known as NK2R[1]. If information was actually sought for TACR2 or NK2R (a G protein-coupled receptor), refer directly to its established gene/protein entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to TACR2 (ENSG00000299486).